Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen

Nigel J Bundred; Elizabeth Anderson; Robert I Nicholson; Mitchell Dowsett; Michael Dixon; John F Robertson

Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen

Nigel J Bundred, Elizabeth Anderson, Robert I Nicholson, Mitchell Dowsett, Michael Dixon, John F Robertson

Deanery of Molecular, Genetic and Population Health Sciences

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

This study was performed to determine whether drug action on breast tumours could also be analysed using a cell turnover index (CTI), a composite measurement of both proliferation and apoptosis.

Original language	English
Pages (from-to)	2317-9
Number of pages	3
Journal	Anticancer research
Volume	22
Issue number	4
Publication status	Published - 2002

Keywords / Materials (for Non-textual outputs)

Antineoplastic Agents
Apoptosis
Breast Neoplasms
Cell Division
Estradiol
Estrogen Receptor Modulators
Female
Humans
Ki-67 Antigen
Kinetics
Placebos
Tamoxifen
Tumor Cells, Cultured

Cite this

@article{80da9c04b21741b1ac956f8388e8fbdd,

title = "Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen",

abstract = "This study was performed to determine whether drug action on breast tumours could also be analysed using a cell turnover index (CTI), a composite measurement of both proliferation and apoptosis.",

keywords = "Antineoplastic Agents, Apoptosis, Breast Neoplasms, Cell Division, Estradiol, Estrogen Receptor Modulators, Female, Humans, Ki-67 Antigen, Kinetics, Placebos, Tamoxifen, Tumor Cells, Cultured",

author = "Bundred, {Nigel J} and Elizabeth Anderson and Nicholson, {Robert I} and Mitchell Dowsett and Michael Dixon and Robertson, {John F}",

year = "2002",

language = "English",

volume = "22",

pages = "2317--9",

journal = "Anticancer research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "4",

}

TY - JOUR

T1 - Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen

AU - Bundred, Nigel J

AU - Anderson, Elizabeth

AU - Nicholson, Robert I

AU - Dowsett, Mitchell

AU - Dixon, Michael

AU - Robertson, John F

PY - 2002

Y1 - 2002

N2 - This study was performed to determine whether drug action on breast tumours could also be analysed using a cell turnover index (CTI), a composite measurement of both proliferation and apoptosis.

AB - This study was performed to determine whether drug action on breast tumours could also be analysed using a cell turnover index (CTI), a composite measurement of both proliferation and apoptosis.

KW - Antineoplastic Agents

KW - Apoptosis

KW - Breast Neoplasms

KW - Cell Division

KW - Estradiol

KW - Estrogen Receptor Modulators

KW - Female

KW - Humans

KW - Ki-67 Antigen

KW - Kinetics

KW - Placebos

KW - Tamoxifen

KW - Tumor Cells, Cultured

M3 - Article

C2 - 12174920

SN - 0250-7005

VL - 22

SP - 2317

EP - 2319

JO - Anticancer research

JF - Anticancer research

IS - 4

ER -

Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen

Abstract / Description of output

Keywords / Materials (for Non-textual outputs)

Fingerprint

Cite this